This specific and semi-quantitative MALDI IMS method showed that the pathogenic sphingolipids are elevated in particular brain areas in the setting of Galc deficiency, which can then help ascertain the efficacy and biodistribution of the upcoming CNS-target therapeutics for GLD. Here, GALC is linked to hyperinsulinemic hypoglycemia, familial, 4.